Related Experiment Video
Updated: Sep 11, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Preferences for implementing pharmacogenomics in pediatric primary care: a discrete choice experiment
Benjamin Q Duong1, Nathan D Seligson2,3, Kelsey J Cook2,3
1Nemours Children's Health, Wilmington, DE, USA.
Background:
Pharmacogenomics services are primarily implemented in adult specialty practices, with limited focus on pediatrics, particularly in primary care. This study aimed to assess primary care providers' preferences for implementing pharmacogenomics services in their practice.
Methods:
A discrete choice experiment using best-worst scaling was designed based on constructs from the Consolidated Framework for Implementation Research (CFIR) domains: Intervention Characteristics, Outer Setting, Inner Setting, Characteristics of Individuals, and Process. Questions and scenarios were developed as a survey to primary care providers at a multistate pediatric health system, to evaluate factors influencing pharmacogenomics service integration.
Results:
Of 165 providers sent the survey, complete responses were received from 68 (41%). The most important constructs from the five CFIR domains were: Evidence Strength and Quality, Patient Needs and Resources, Access to Knowledge and Information, Knowledge and Beliefs, and Engaging and Champions. Least important constructs from the five domains were: Adaptability, Peer Pressure, Culture and Tension for Change, Individual Identification with Organization, and Opinion Leaders and External Change Agents.
Conclusion:
Primary care providers from this pediatric institution identified specific features essential for implementation of a pharmacogenomics service including engaging practitioners/champions, providing education, and establishing access to pharmacogenomic evidence and resources for providers and patients.
Impact:
Understanding pediatric providers' needs in implementing pharmacogenomics services, including education, resources, and organizational culture, is an underexplored area. The findings support informed strategies to integrate pharmacogenomics into pediatric care, enhancing its adoption into pediatric primary care. This study offers new insights into the pediatric primary care perspective on pharmacogenomics service implementation, highlighting essential priorities such as practitioner champions, targeted education, evidence access, and resource adequacy across a multistate pediatric institution.
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Factors Affecting Drug Response: Overview
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.

